News
Verve Therapeutics, Inc.’s VERV share price has surged by 9.05%, which has investors questioning if this is right time to sell.
For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment ...
Researchers in Canada are developing a low-cost orthovoltage radiotherapy system for use in low-resource and geographically remote regions ...
Tuesday, April 15 marked a historic milestone for Methodist University − and for the future of healthcare in Southeastern North Carolina − as leaders from Methodist University and Cape Fear Valley ...
2d
Investor's Business Daily on MSNWhy Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable BoostShares of gene therapy companies — including Sarepta Therapeutics — got a lift Monday after FDA's Marty Makary laid out his plans.
With its patented, AI-powered, FDA-certified transmission X-ray technology, since 2007 NanoRay Biotech is radically transforming medical and industrial X-ray applications in Taiwan and aims to further ...
Missouri Tigers All-American Helen Hu hangs in the air as she competes on the uneven bars during the NCAA Women’s Gymnastics ...
Radiation therapy for gastrointestinal cancers is more precise and easier to tolerate due newer technologies and personalized ...
Telix Pharmaceuticals Ltd.’s glioblastoma theranostic, TLX-101, is showing promising overall survival in a phase II trial in ...
Leaders from Methodist University and Cape Fear Valley Health gathered with the community April 15 to celebrate the final ...
Stubbs & Wootton and Maus & Hoffman are set to kick off their popular season-ending sales with deals up to 50% off.
Raffles will be in support of the Kids with Cancer Society, Ben Stelter Foundation and Alberta Cancer Foundation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results